Resources for You
Alimta (pemetrexed for injection) for intravenous use, 100 mg and 500 mg vials
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
- These reactions occurred with Alimta when used as a single-agent and in combination therapies.
- Blood and Lymphatic System — immune-mediated hemolytic anemia